Queensland Drug Repurposing Initiative

The Queensland Drug Repurposing Initiative (QDRI) aims to fast-track new treatments for neurodegenerative diseases such as Parkinson’s disease.

Our research investigates whether drugs already approved to treat other diseases can also help treat neurodegeneration.

Phase II clinical trials will be conducted in major Queensland hospitals and research centres for drugs prioritised by an international expert panel after showing robust evidence of their potential to be effective. 

Our team will create a large-scale clinical drug repurposing and biomarkers initiative in partnership with the UK Cure Parkinson’s Trust (CPT) and Linked Clinical Trials Initiative (LCT) with funding from the Advance Queensland program and Shake It Up Australia Foundation.

This initiative will establish Queensland as a hub for drug repurposing research while rapidly advancing cost-effective treatments for neurodegenerative diseases towards the clinic.

Please contact our clinical trials team if you are a person with Parkinson’s disease and are interested in participating in our clinical trials.

Contact

Clinical Trials Coordinator
Helen Woodhouse
h.woodhouse@uq.edu.au
07 3346 5043

Clinical Trials Manager
Dr Sophie Rowbotham
s.rowbotham@uq.edu.au
07 3346 5418

Chief investigators

Research collaborators

QDRI staff

  • Dr Sophie Rowbotham

    Dr Sophie Rowbotham

    Clinical Trials Manager
    UQ Centre for Clinical Research
  • Dr Kerry Roper

    Dr Kerry Roper

    Casual Senior Research Technician & Postdoctoral Research Fellow
    UQ Centre for Clinical Research
  • Helen Woodhouse

    Mrs Helen Woodhouse

    Casual Clinical Researc Coordinator & Clinical Trials Coordinator
    UQ Centre for Clinical Research
  • Natalia Birch

    Miss Natalia Birch

    Senior Research Technician
    UQ Centre for Clinical Research

Our clinical trials will evaluate the efficacy of prioritised repurposed drugs as promising disease-modifying treatments for Parkinson’s disease. These drugs have been shortlisted by the Cure Parkinson’s Trust Linked Clinical Trials (LCT) program and have been rigorously evaluated for their potential to slow or halt the progression of the disease. 

Phase II clinical trials will be conducted at major Queensland hospitals and clinical research centres. We will be recruiting at multiple clinical trial sites from across Queensland including:

  • Royal Brisbane Hospital and UQ Centre for Clinical Research (UQCCR)
  • Wesley Hospital and Wesley Medical Research  
  • Gold Coast University Hospital and Griffith Health Centre
  • Sunshine Coast University Hospital
  • Townsville Hospital

Enrolment in clinical trials

Please contact our clinical trials team if you are a person with Parkinson’s disease and are interested in participating in our clinical trials.

Clinical Trials Coordinator
Helen Woodhouse
Email: h.woodhouse@uq.edu.au
Tel: 07 3346 5043

Clinical Trials Manager
Dr Sophie Rowbotham
Email: s.rowbotham@uq.edu.au
Tel: 07 3346 5418

Our ancillary clinical research projects are focused on discovery and validation of clinical biomarkers for Parkinson’s disease and to evaluate the effectiveness of the drugs that are being tested in our clinical trials.  There are currently no available biomarkers to conclusively diagnose the onset of Parkinson’s disease or to track its progression in people diagnosed with the disease. Our research is using multidisciplinary approaches to discover and confirm novel markers of disease onset and progression.

Enrolment in clinical research projects

We are currently seeking people with Parkinson’s disease as well as healthy control participants for our biomarkers research program. If you are interested in participating in any of our ongoing clinical research projects please contact our clinical research team.

Clinical Trials Coordinator
Helen Woodhouse
Email: h.woodhouse@uq.edu.au
Tel: 07 3346 5043

Clinical Trials Manager
Dr Sophie Rowbotham
Email: s.rowbotham@uq.edu.au
Tel: 07 3346 5418

To donate to drug repurposing research, click on the button below.

When choosing a giving destination, please select "Other", then specify: Queensland Drug Repurposing Initiative.

Donate

Our partners

Advance Queensland logo

Shake It Up Australia logo

The Cure Parkinson's Trust logo

Wesley Medical Research logo

Griffith University logo